skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis

Menter, Alan, MD ; Thaçi, Diamant, MD ; Papp, Kim A., MD ; Wu, Jashin J., MD ; Bereswill, Mareike, MS ; Teixeira, Henrique D., PhD ; Rubant, Simone, PhD ; Williams, David A., MD

Journal of the American Academy of Dermatology, 2015-09, Vol.73 (3), p.410-419.e6 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent
Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent

Yamauchi, Paul S., MD, PhD ; Bissonnette, Robert, MD ; Teixeira, Henrique D., PhD, MBA ; Valdecantos, Wendell C., MD

Journal of the American Academy of Dermatology, 2016-09, Vol.75 (3), p.612-618.e6 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice

Prens, Errol P. ; Lugo-Somolinos, Aida M. ; Paller, Amy S. ; Kerdel, Francisco ; Duan, Yinghui ; Teixeira, Henrique D. ; Longcore, Michelle ; Kimball, Alexa B.

American journal of clinical dermatology, 2020-08, Vol.21 (4), p.579-590 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
4
Effect of education and multimorbidity on mortality among older adults: findings from the health, well-being and ageing cohort study (SABE)
Effect of education and multimorbidity on mortality among older adults: findings from the health, well-being and ageing cohort study (SABE)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of education and multimorbidity on mortality among older adults: findings from the health, well-being and ageing cohort study (SABE)

Bernardes, G.M. ; Saulo, H. ; Santos, J.L.F. ; da Cruz Teixeira, D.S. ; de Oliveira Duarte, Y.A. ; Andrade, F. Bof de

Public health (London), 2021-12, Vol.201, p.69-74 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Guttman-Yassky, Emma ; Teixeira, Henrique D ; Simpson, Eric L ; Papp, Kim A ; Pangan, Aileen L ; Blauvelt, Andrew ; Thaçi, Diamant ; Chu, Chia-Yu ; Hong, H Chih-ho ; Katoh, Norito ; Paller, Amy S ; Calimlim, Brian ; Gu, Yihua ; Hu, Xiaofei ; Liu, Meng ; Yang, Yang ; Liu, John ; Tenorio, Allan R ; Chu, Alvina D ; Irvine, Alan D

The Lancet (British edition), 2021-06, Vol.397 (10290), p.2151-2168 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Stomatological disorders in older people: An epidemiological study in the Brazil southern
Stomatological disorders in older people: An epidemiological study in the Brazil southern
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stomatological disorders in older people: An epidemiological study in the Brazil southern

Fattori, E ; Teixeira, D-S ; de Figueiredo, M-A-Z ; Cherubini, K ; Salum, F-G

Medicina oral, patología oral y cirugía bucal, 2019-09, Vol.24 (5), p.e577-e582 [Periódico revisado por pares]

Spain: Medicina Oral S.L

Texto completo disponível

Citações Citado por
7
Smoking status and its relationship with exercise capacity, physical activity in daily life and quality of life in physically independent, elderly individuals
Smoking status and its relationship with exercise capacity, physical activity in daily life and quality of life in physically independent, elderly individuals
Material Type:
Artigo 		Adicionar ao Meu Espaço

Smoking status and its relationship with exercise capacity, physical activity in daily life and quality of life in physically independent, elderly individuals

Mesquita, R ; Gonçalves, C.G ; Hayashi, D ; Costa, V. de S.P ; Teixeira, D. de C ; de Freitas, E.R.F.S ; Felcar, J.M ; Pitta, F ; Molari, M ; Probst, V.S

Physiotherapy, 2015-03, Vol.101 (1), p.55-61 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials
Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

Jemec, G.B.E. ; Okun, M.M. ; Forman, S.B. ; Gulliver, W.P.F. ; Prens, E.P. ; Mrowietz, U. ; Armstrong, A.W. ; Geng, Z. ; Gu, Y. ; Williams, D.A. ; Teixeira, H.D. ; Kimball, A.B.

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.967-975 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
9
Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS)
Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS)

Foley, Catherine ; Tundia, Namita ; Simpson, Eric ; Teixeira, Henrique D. ; Litcher-Kelly, Leighann ; Bodhani, Amit

Current medical research and opinion, 2019-07, Vol.35 (7), p.1139-1148 [Periódico revisado por pares]

England: Taylor & Francis

Texto completo disponível

Citações Citado por
10
Exposure‐Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis—Analyses of Phase 2b Study to Support Selection of Phase 3 Doses
Exposure‐Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis—Analyses of Phase 2b Study to Support Selection of Phase 3 Doses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Exposure‐Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis—Analyses of Phase 2b Study to Support Selection of Phase 3 Doses

Mohamed, Mohamed‐Eslam F. ; Gopalakrishnan, Sathej ; Teixeira, Henrique D. ; Othman, Ahmed A.

Journal of clinical pharmacology, 2021-05, Vol.61 (5), p.628-635 [Periódico revisado por pares]

England: American College of Clinical Pharmacology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (340)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (356)
  2. Anais de Congresso  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1997  (9)
  2. 1997Até2002  (21)
  3. 2003Até2008  (62)
  4. 2009Até2015  (133)
  5. Após 2015  (134)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (353)
  2. Japonês  (43)
  3. Português  (40)
  4. Russo  (1)
  5. Francês  (1)
  6. Espanhol  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.